TransMed Research offers drug-screening assay with the newest high throughput technology (HCS, High Content Screening) in cellular models.
Analyzing millions of cells, treated with different compounds or chemical entities simultaneously and rapidly, HCS enables maximize information in terms of predicting the activity and the safety of a drug candidate.
To this end, we generate in vitro models in 96- to 384-well format for screening primary cell cultures or cell lines on a panel of dozens of morphological and molecular readouts such as cytotoxicity, cell cycle analysis, neuronal differentiation, cell morphology features and more.
Download more info
or email us at email@example.com